IO-120

N/A

Report date: 2026/03/15 20:00:14

Base Information

Drug NameIO-120
Drug Alias NameIO-120
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionProgrammed death-ligand 2 modulators
TargetsProgrammed death-ligand 2
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIo Biotech Aps
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIo Biotech Aps
Active IndicationsN/A
Inactive IndicationsLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A